缅北禁地

close

TAGGED : cancer

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU庐 (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

FLORENCE, Italy & HONG KONG--(BUSINESS WIRE)--Nov 7, 2023--The Menarini Group (鈥淢enarini鈥), a leading international pharmaceutical and diagnostics company, and SciClone Pharmaceuticals (Holdings) Ltd. (鈥淪ciClone鈥), an international biopharmaceutical company, today announced ...

Agenus Reports Third Quarter 2023 Results

LEXINGTON, Mass.--(BUSINESS WIRE)--Nov 7, 2023--Agenus Inc. (鈥淎genus鈥) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced results for the third quarter 2023. Agenus executives will host a conference call and webcast at ...